FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan
      Dashboard

      Novartis Sees Avidity Drug Fail in Third Setback in a Week

      Novartis suffered its third clinical-trial setback in a week after del-desiran, a treatment for a rare muscle-wasting disease, failed a late-stage study.


      Source: Bloomberg
      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud